Schizophrenia is a debilitating and complex mental disorder with a prevalence of approximately 1% worldwide. Its pathophysiology remains unclear, despite extensive research.
1,2 Biochemical and pharmacological studies using human samples and animal models suggest that oxidative/carbonyl stress contributes to the pathophysiology of schizophrenia.
3-6 Oxidative stress is a central mediator of advanced glycation end product (AGE) formation, and pyridoxamine (vitamin B
6, biosynthesized from pyridoxal in vivo) is known to detoxify reactive carbonyl compounds via carbonyl-amine chemistry. Toxic reactive carbonyl compounds such as α-oxoaldehydes (eg, methylglyoxal, glyoxal, and 3-deoxyglucosone) are formed from sugars, lipids, and amino acids.
7-9 Accumulation of such reactive carbonyl compounds, referred to as carbonyl stress,
10 results in the modification of proteins and the eventual formation of AGEs such as pentosidine. Cellular removal of AGEs hinges largely on the activity of the zinc metalloenzyme glyoxalase I (GLO1).
11 The glyoxalase detoxification system is ubiquitous in human tissues, including the brain. The GLO1 detoxification system interacts with several metabolizing cascades, and some compounds in these cascades have been reported as candidates for involvement in the etiology of schizophrenia, such as glutathione, homocysteine, and folic acid metabolites (eFigure 1, available at http://www.prit.go.jp/En/PSchizo/TSchizo/archives.html).
12-19